Stoke Therapeutics (STOK) Return on Assets (2019 - 2026)

Stoke Therapeutics' Return on Assets history runs 8 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Assets fell 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (down 1.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets was 0.0% for Q1 2026 at Stoke Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2025 to a low of 0.01% in Q1 2024.
• Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
• The sharpest annual moves came in 2025 and 2026: Return on Assets gained 1 bps in 2025, then slipped 1 bps in 2026.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then fell by 18 bps to 0.0% in 2023, then climbed by 30 bps to 0.0% in 2024, then surged by 94 bps to 0.0% in 2025, then plunged by 2163 bps to 0.0% in 2026.
• The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.